BioKeralty Research Institute is part of Keralty group’s research, development and innovation (R&D&I) division. Following the Keralty’s health model principles, BioKeralty drives and coordinates research and development projects in several health areas. The main research areas are: chronic diseases, regenerative medicine, cancer, personalized medicine or digital health, as well as health value, social care and community care.
Thought its participation in several partnerships, R&D&I projects and related calls, Keralty group works in the implementation of attention models, management models and health technologies and tools. In this way, Keralty aims to create competitive advantage that will allow the group share and add value to its patients and health professionals.
Kick-off of the European project CARAMEL: an innovative approach to cardiovascular disease prevention in menopausal women 03/12/2024 CARAMEL (CArdiovascular Risk Assessment via multimodal data analysis enabling personalized prevention strategies targeting MEnopausal Women), a European project funded by Horizon Europe, was launched on…
BioKeralty news BioKeralty searches for innovative solutions able to optimize the manufacture of cornea substitutes The initiative is part of the Nanogrow project which seeks to shorten manufacturing times and increase the effectiveness and tolerance of autograft In the image, lipid nanoparticles…
For those people interested in the scientific publications and patents developed by the BioKeralty team, this section gathers detailed information and useful references corresponding to its scientific research.
Nanomaterials, biomedical applications, in vitro and in vivo antimicrobial activities, nanomedicine, fatty acids, nanofibrous membranes, tissue reparations, etc. constitute some of the research topics included in this section.
Primary care
Cancer
Chronic and neurodegenerative
Infectious diseases
E-health
Genomics and personalized
Regenerative medicine
Nanotechnology
Education
Community
Social
Health value